BR100 Increased By (0.02%)
BR30 Increased By (0.06%)
KSE100 Decreased By (-0%)
KSE30 Increased By (0.05%)
BECO 5.52 Decreased By ▼ -0.02 (-0.36%)
BML 56.70 Decreased By ▼ -0.39 (-0.68%)
BOP 35.20 Decreased By ▼ -0.01 (-0.03%)
CNERGY 8.15 Decreased By ▼ -0.05 (-0.61%)
DCL 11.61 Decreased By ▼ -0.03 (-0.26%)
FCCL 56.61 Increased By ▲ 0.12 (0.21%)
FCSC 5.38 Increased By ▲ 0.06 (1.13%)
FFL 17.95 Decreased By ▼ -0.11 (-0.61%)
FNEL 1.29 No Change ▼ 0.00 (0%)
HUMNL 11.10 Decreased By ▼ -0.09 (-0.8%)
KEL 8.39 Increased By ▲ 0.19 (2.32%)
KOSM 6.63 Decreased By ▼ -0.04 (-0.6%)
MLCF 101.06 Increased By ▲ 0.30 (0.3%)
NBP 202.44 Decreased By ▼ -0.56 (-0.28%)
PACE 11.42 Decreased By ▼ -0.07 (-0.61%)
PAEL 43.32 Increased By ▲ 0.24 (0.56%)
PIAHCLA 27.24 Increased By ▲ 0.24 (0.89%)
PIBTL 17.82 Decreased By ▼ -0.02 (-0.11%)
PPL 244.79 Increased By ▲ 2.16 (0.89%)
PRL 35.71 Decreased By ▼ -0.16 (-0.45%)
PTC 65.45 Decreased By ▼ -0.40 (-0.61%)
SEARL 93.55 Decreased By ▼ -0.03 (-0.03%)
SSGC 32.98 Increased By ▲ 0.75 (2.33%)
TELE 9.04 Decreased By ▼ -0.07 (-0.77%)
THCCL 66.80 Increased By ▲ 0.31 (0.47%)
TPLP 10.85 Decreased By ▼ -0.10 (-0.91%)
TREET 25.48 Decreased By ▼ -0.24 (-0.93%)
TRG 65.90 Decreased By ▼ -0.05 (-0.08%)
WAVES 11.13 Decreased By ▼ -0.03 (-0.27%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
World

Serbia gets Chinese-made Sinopharm jabs

  • Serbia has registered nearly 370,000 infections and more than 3,700 deaths from the novel coronavirus.
Published January 16, 2021 Updated January 16, 2021 05:19pm
By

BELGRADE: Serbia became one of the first European countries to receive a Chinese-made Covid-19 vaccine on Saturday when one million doses of a jab produced by Sinopharm arrived at Belgrade airport.

President Aleksandar Vucic posted a picture of himself on Instagram, standing next to the plane carrying the vaccine.

"We are proud of our friendship with China," he was quoted as saying by Beta news agency, telling reporters that he hoped to be inoculated with the Sinopharm vaccine in six or seven days.

After Pfizer-BioNTech and Russia's Sputnik V, Sinopharm's is the third coronavirus vaccine to be used by the Balkan nation.

Once the Chinese vaccine gets a final approval by Serbia's medicines agency, vaccination could start on Sunday or Monday, health official Zoran Gojkovic said earlier.

The European Union-candidate country, which has also close economic and political ties with Moscow and Beijing, started vaccination with Pfizer-BioNTech jabs on December 24 and later imported Russian Sputnik V vaccines.

Sinopharm says its vaccine is 79 percent effective against the novel coronavirus, compared with rates of 95 percent and 94 percent respectively for the rival jabs made by Pfizer-BioNTech and Moderna.

Another Chinese-made jab, Sinovac's CoronaVac, was rolled out in Turkey on Thursday, after tests there showed it to be 91.25 percent effective.

But more robust trials in Brazil demonstrated an efficacy rate of around 50 percent.

So far, some 20,500 people -- residents of retirement homes and health sector employees -- have been vaccinated in Serbia, a country with a population of seven million, the national immunisation team said Friday.

Serbia has registered nearly 370,000 infections and more than 3,700 deaths from the novel coronavirus.

Comments

Comments are closed for this article.